Karim Khader
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Clostridium difficile and Clostridium perfringens research 19
- Antimicrobial Resistance in Staphylococcus 11
-
- Antibiotic Resistance in Bacteria 8
- Co-authors
- Matthew H. Samore (37 shared papers)Richard E. Nelson (26 shared papers)Marin L. Schweizer (14 shared papers)Vanessa Stevens (22 shared papers)Michael Rubin (20 shared papers)Eli N. Perencevich (12 shared papers)Makoto Jones (21 shared papers)Amy Blevins (8 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (9 papers)Open Forum Infectious Diseases (8 papers)Clinical Infectious Diseases (6 papers)Antimicrobial Resistance and Infection Control (4 papers)JAMA Network Open (3 papers)
- Partner nations
- United StatesSwitzerlandTaiwan
In The Last Decade
Karim Khader
49 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Applied Microbiology and Biotechnology 142
- Molecular Medicine 255
- Infectious Diseases 504
- Clinical Biochemistry 122
- Critical Care and Intensive Care Medicine 73
Countries citing papers authored by Karim Khader
This map shows the geographic impact of Karim Khader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Khader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Khader more than expected).
Fields of papers citing papers by Karim Khader
This network shows the impact of papers produced by Karim Khader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Khader. The network helps show where Karim Khader may publish in the future.
Co-authors
The 25 scholars most cited alongside Karim Khader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 127 | |
| 2 | 2017 | 124 | |
| 3 | 2020 | 95 | |
| 4 | 2018 | 93 | |
| 5 | 2016 | 90 | |
| 6 | 2017 | 61 | |
| 7 | 2016 | 45 | |
| 8 | 2017 | 41 | |
| 9 | 2013 | 40 | |
| 10 | 2020 | 40 | |
| 11 | 2015 | 39 | |
| 12 | 2016 | 31 | |
| 13 | 2019 | 28 | |
| 14 | 2015 | 21 | |
| 15 | 2021 | 19 | |
| 16 | 2020 | 14 | |
| 17 | 2022 | 12 | |
| 18 | 2013 | 11 | |
| 19 | 2014 | 11 | |
| 20 | 2020 | 9 |
About Karim Khader
Karim Khader is a scholar working on Infectious Diseases, Molecular Medicine, Applied Microbiology and Biotechnology, Clinical Biochemistry and General Health Professions, having authored 54 papers that have together received 1.1k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (19 papers), Antimicrobial Resistance in Staphylococcus (11 papers), Antibiotic Resistance in Bacteria (8 papers), Antibiotic Use and Resistance (8 papers), Bacterial Identification and Susceptibility Testing (7 papers), Emergency and Acute Care Studies (5 papers), Healthcare cost, quality, practices (4 papers) and Nosocomial Infections in ICU (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (142 citations), Molecular Medicine (255 citations), Infectious Diseases (504 citations), Clinical Biochemistry (122 citations) and Critical Care and Intensive Care Medicine (73 citations). Karim Khader has collaborated with scholars based in United States, Switzerland and Taiwan. Frequent co-authors include Matthew H. Samore, Richard E. Nelson, Marin L. Schweizer, Vanessa Stevens, Michael Rubin, Eli N. Perencevich, Makoto Jones, Amy Blevins, Rajeshwari Nair and Hsiu‐Yin Chiang. Their work appears in journals such as Infection Control and Hospital Epidemiology, Open Forum Infectious Diseases, Clinical Infectious Diseases, Antimicrobial Resistance and Infection Control and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.